Quality of reporting internal and external validity data from randomized controlled trials evaluating stents for percutaneous coronary intervention

نویسندگان

  • Morgane Ethgen
  • lsabelle Boutron
  • Philippe Gabriel Steg
  • Carine Roy
  • Philippe Ravaud
چکیده

BACKGROUND Stents are commonly used to treat patients with coronary artery disease. However, the quality of reporting internal and external validity data in published reports of randomised controlled trials (RCTs) of stents has never been assessed.The objective of our study was to evaluate the quality of reporting internal and external validity data in published reports of RCTs assessing the stents for percutaneous coronary interventions. METHODS A systematic literature review was conducted. Reports of RCTs assessing stents for percutaneous coronary interventions indexed in MEDLINE and the Cochrane Central Register of Controlled Trials and published between January 2003 and September 2008 were selected. A standardized abstraction form was used to extract data. All analyses were adjusted for the effect of clustering articles by journal. RESULTS 132 articles were analyzed. The generation of the allocation sequence was adequate in 58.3% of the reports; treatment allocation was concealed in 34.8%. Adequate blinding was reported in one-fifth of the reports. An intention-to-treat analysis was described in 79.5%. The main outcome was a surrogate angiographic endpoint in 47.0%. The volume of interventions per center was described in two reports. Operator expertise was described in five (3.8%) reports. The quality of reporting was better in journals with high impact factors and in journals endorsing the CONSORT statement. CONCLUSION The current reporting of results of RCTs testing stents needs to be improved to allow readers to appraise the risk of bias and the applicability of the results.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention

BACKGROUND The aim of this study was to assess the reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention. METHODS The study design was a methodological systematic review of randomized controlled trials. The data sources were MEDLINE and the Cochrane Central Register of Controlled Trials. All reports of randomized controlled trials assessing...

متن کامل

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials

Background. Individual randomized trials have suggested that everolimus-eluting stents may have improved clinical outcomes compared to paclitaxel-eluting stents, but individual trials are underpowered to examine outcomes such as mortality and very late stent thrombosis. Methods. Medline, Cochrane, and conference proceedings were searched for randomized trials comparing everolimus versus paclita...

متن کامل

Revascularization Strategy for Proximal LAD Disease

SEE PAGE 2717 S ignificant proximal left anterior descending artery (LAD) disease may jeopardize up to 50% of the left ventricular myocardium (1) and predicts worse outcomes (2), with a significantly worse 5-year patient survival rate (90% vs. 98%) than downstream LAD lesions (3). In the 1990s, randomized controlled trials (RCTs) showed that all treatment modalities, namely, medical therapy, pe...

متن کامل

Clinical outcomes of biodegradable polymer drug-eluting stents for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trials.

Biodegradable polymer drug-eluting stents (DES) are innovative concepts in the era of percutaneous coronary intervention. We systematically reviewed the latest randomized evidence on the efficacy and safety of biodegradable polymer DES as compared to durable polymer DES. MEDLINE, Embase, and the Cochrane database were searched in August 2013 for eligible randomized controlled trials (RCTs) comp...

متن کامل

Drug-eluting stents vs bypass surgery for multivessel disease.

To the Editor: We read with great interest the study by Yamagata et al of percutaneous coronary intervention (PCI) using sirolimuseluting stents vs off-pump coronary artery bypass grafting (CABG) in diabetic patients with multivessel disease (MVD).1 Despite a non-randomized retrospective analysis, however, any statistical adjustment (eg, propensity score analysis or Cox proportional hazards reg...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 9  شماره 

صفحات  -

تاریخ انتشار 2009